TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Aurena Laboratories Holding AB
Closing information (x1000 DKK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
179,219
|
166,958
|
147,146 |
| Financial expenses |
3,304
|
2,019
|
1,103 |
| Earnings before taxes |
15,999
|
12,841
|
9,206 |
| EBITDA |
24,958
|
19,706
|
13,816 |
| Total assets |
154,033
|
145,123
|
131,899 |
| Current assets |
65,749
|
58,272
|
60,713 |
| Current liabilities |
32,077
|
30,018
|
35,628 |
| Equity capital |
86,180
|
78,697
|
69,564 |
| - share capital |
325
|
336
|
334 |
| Employees (average) |
86
|
79
|
76 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
55.9%
|
54.2%
|
52.7% |
| Turnover per employee |
2,084
|
2,113
|
1,936 |
| Profit as a percentage of turnover |
8.9%
|
7.7%
|
6.3% |
| Return on assets (ROA) |
12.5%
|
10.2%
|
7.8% |
| Current ratio |
205.0%
|
194.1%
|
170.4% |
| Return on equity (ROE) |
18.6%
|
16.3%
|
13.2% |
| Change turnover |
17,783
|
19,055
|
17,589 |
| Change turnover % |
11%
|
13%
|
14% |
| Chg. No. of employees |
7
|
3
|
0 |
| Chg. No. of employees % |
9%
|
4%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.